The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastomaSilvia Lampis, Roberto Tonelli|Journal of Experimental & Clinical Cancer Research|2022Cited by 23
Antigene MYCN Silencing by BGA002 Inhibits SCLC Progression Blocking mTOR Pathway and Overcomes Multidrug ResistanceSonia Bortolotti, Roberto Tonelli|Cancers|2023Cited by 8